Delivery Order SPE2DB24D2205-SPE2DB25FEAKU
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,239.74, is for the delivery of 4,567,908,195 units of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of January 24, 2025 and a ceiling value of $15,714.20. AmerisourceBergen is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a wide range...
This is a $10,575.18 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,567,105,075 units of Candesartan Cilexetil 32 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,264.64 delivery order is for the supply of Candesartan Cilexetil 32 mg tablets, with a completion date of May 15, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,734.76, is for the supply of Candesartan Cilexetil 8 mg tablets. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corporation holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,498.49, is for the delivery of 32 mg Candesartan Cilexetil tablets in 90-count bottles. The contract is a firm fixed-price delivery order with a completion date of March 13, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Candesartan Cilexetil 32 mg tablets. The contract, valued at $4,504.88, has a firm fixed-price pricing type and an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order. The contract does not have a set-aside designation. AmerisourceBergen also holds several indefinite delivery...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 8 mg tablets. The contract, valued at $1,113.48, has a period of performance through February 4, 2025 and is a Firm Fixed Price contract type. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award, valued at $12,009.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Candesartan Cilexetil 32 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period through January 30, 2025. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for...
This is a $31,487.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,824,771 units of Candesartan Cilexetil 16 mg tablets. The contract has a completion date of January 3, 2025 and was awarded on January 2, 2025. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) that Amerisourcebergen...